GlassScriptPhysician profile
Steven Vanni
NPI 1659396448
$1,141,054.28
in general payments reported to CMS, 2019-2025
32 companies · $61K in 2025
The $61K reported for 2025 was more than what 96% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $180K · 2020: $218K · 2021: $190K · 2022: $257K · 2023: $141K · 2024: $94K · 2025: $61K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $267K · Travel and Lodging: $15K · Consulting Fee: $9,675 · Food and Beverage: $4,685.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $266,528.03 |
| Travel and Lodging | $14,790.14 |
| Consulting Fee | $9,675.00 |
| Food and Beverage | $4,685.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $579,933.68 | 2019-2023 | Vuepoint, Xlif, Reline |
| Globus Medical, INC. | $329,866.69 | 2019-2025 | Altera, Creo 5.5, Senza |
| Spine Wave, INC. | $181,793.25 | 2019-2024 | Salvo Spine System, Sniper Spine System, Leva Anterior Interbody System |
| Surgalign Spine Technologies, INC. | $14,790.56 | 2019-2021 | |
| Spineart USA INC | $12,682.40 | 2023-2024 | Perla Tl |
| Xtant Medical INC | $10,305.20 | 2022-2025 | |
| Zavation Medical Products, LLC | $3,812.15 | 2024-2025 | |
| Seaspine Orthopedics Corporation | $2,388.00 | 2020-2021 | |
| Aesculap Implant Systems, LLC | $1,530.73 | 2019 | |
| Spineart Sa | $808.59 | 2024 | |
| Medtronic USA, INC. | $478.84 | 2019 | |
| Abbott Laboratories | $388.25 | 2019-2023 | Proclaim, Prodigy |
| Centinel Spine, LLC | $383.39 | 2019 | |
| Depuy Synthes Sales INC. | $252.24 | 2023-2024 | Viper, Expedium Verse |
| Integrity Implants INC. | $235.25 | 2019-2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $220.71 | 2021-2023 | Unid_pass, Clydesdale Ptc Spinal System, Mazor X System |
| Nevro Corp. | $195.94 | 2019-2023 | Senza |
| Orthofix Medical, INC. | $170.84 | 2022-2025 | Spinal-Stim, Cervical-Stim, Spinal-Stim |
| Osseus Fusion Systems, LLC | $162.43 | 2019 | |
| Lemaitre Vascular, INC. | $125.00 | 2022 | |
| Cerapedics INC. | $89.82 | 2024-2025 | I-Factor Peptide Enhanced Bone Graft |
| Saluda Medical Americas, INC. | $87.73 | 2025 | Evoke |
| Si-Bone, INC. | $75.14 | 2022-2025 | |
| Stryker Corporation | $67.09 | 2023 | Niagara Lateral Access System |
| Ethicon US, LLC | $42.26 | 2022 | |
| Vb Spine LLC | $33.26 | 2025 | Niagara Lateral Access System |
| Bsn Medical INC | $31.25 | 2022 | |
| Carlsmed, INC. | $29.71 | 2025 | Aprevo |
| Novocure INC. | $20.01 | 2024 | Optune |
| Biotissue Holdings INC. | $20.00 | 2023 | |
| Providence Medical Technology, INC. | $17.02 | 2022 | |
| Zimvie INC. | $16.85 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Vanni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.